According to the CVS Health 2025 Rx Report, nearly half of consumers prioritize personalized care at the pharmacy, and many prefer in-person pharmacy support over digital-only options - highlighting the ongoing importance of face-to-face interactions with pharmacists
Semaglutide: The Weight Loss Breakthrough Semaglutide is a relatively new peptide for weight loss, similar to dulaglutide
Before starting Wegovy , inform your healthcare provider if you have: History of pancreatitis or gallbladder disease Pre-existing gastrointestinal conditions including inflammatory bowel disease or diverticular disease Severe gastrointestinal disease If you are pregnant, breastfeeding, or planning pregnancy (Wegovy must be stopped at least 2 months before planned conception) Regular follow-up with your prescribing clinician is essential to monitor treatment response, manage side effects, and ensure the medication remains appropriate for your individual circumstances
It targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, which can lead to even more significant weight loss for some individuals
Low iron, low B12, and low vitamin D can show up in people with ongoing gut trouble
"Risk of incident coronary artery disease in patients with primary biliary cirrhosis"